(Q33284848)

25 July 2017

title

Upregulation of PTEN involved in rosiglitazone-induced apoptosis in human hepatocellular carcinoma cells (English)

1 reference

25 July 2017

main subject

hepatocellular carcinoma

1 reference

Liang-Qi Cao

1

1 reference

25 July 2017

Xi-Lin Chen

2

1 reference

25 July 2017

Qian Wang

3

1 reference

25 July 2017

Xiao-Hui Huang

4

1 reference

25 July 2017

Mao-Chuan Zhen

5

1 reference

25 July 2017

Long-Juan Zhang

6

1 reference

25 July 2017

Wen Li

7

1 reference

25 July 2017

Jiong Bi

8

1 reference

25 July 2017

publication date

1 June 2007

1 reference

Acta Pharmacologica Sinica

25 July 2017

published in

1 reference

25 July 2017

volume

28

1 reference

25 July 2017

issue

6

1 reference

25 July 2017

page(s)

879-887

1 reference

https://scigraph.springernature.com/pub.10.1111/j.1745-7254.2007.00571.x

25 July 2017

exact match

0 references

cites work

Global cancer statistics in the year 2000.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00571.X

Differential anti-proliferative actions of peroxisome proliferator-activated receptor-gamma agonists in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00571.X

Redox regulation of PI 3-kinase signalling via inactivation of PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00571.X

Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00571.X

Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00571.X

Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00571.X

Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00571.X

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00571.X

The phosphoinositide 3-kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00571.X

AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00571.X

Cyclooxygenase-2 inhibits novel ginseng metabolite-mediated apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00571.X

15-Deoxy-Δ-12-14-PGJ2 Regulates Apoptosis Induction and Nuclear Factor-κB Activation Via a Peroxisome Proliferator-Activated Receptor-γ–Independent Mechanism in Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00571.X

Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00571.X

Role of AKT kinase in sphingosine-induced apoptosis in human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00571.X

Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00571.X

Critical role of c-Jun N-terminal protein kinase activation in troglitazone-induced apoptosis of human HepG2 hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00571.X

Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00571.X

A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00571.X

15-Deoxy-delta12,14-prostaglandin J2, a ligand for peroxisome proliferators-activated receptor-gamma, induces apoptosis in human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00571.X

PTEN: a crucial mediator of mitochondria-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00571.X

10.1111/J.1745-7254.2007.00571.X

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

25 July 2017

1004590948

0 references

1 reference